HomeELDN • NASDAQ
add
Eledon Pharmaceuticals Inc
Previous close
$3.00
Day range
$2.93 - $3.12
Year range
$1.56 - $5.54
Market cap
179.65M USD
Avg Volume
253.87K
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
Market news
Financials
Income Statement
Revenue
Net income
| (USD) | Dec 2024info | Y/Y change |
|---|---|---|
Revenue | — | — |
Operating expense | 24.70M | 138.89% |
Net income | -44.62M | -48.23% |
Net profit margin | — | — |
Earnings per share | -0.95 | -226.07% |
EBITDA | — | — |
Effective tax rate | -0.98% | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | Dec 2024info | Y/Y change |
|---|---|---|
Cash and short-term investments | 140.18M | 174.31% |
Total assets | 177.40M | 99.18% |
Total liabilities | 59.26M | -27.60% |
Total equity | 118.14M | — |
Shares outstanding | 59.88M | — |
Price to book | 1.52 | — |
Return on assets | -42.29% | — |
Return on capital | -63.11% | — |
Cash Flow
Net change in cash
| (USD) | Dec 2024info | Y/Y change |
|---|---|---|
Net income | -44.62M | -48.23% |
Cash from operations | -18.99M | -107.94% |
Cash from investing | -47.38M | -570.25% |
Cash from financing | 80.17M | — |
Net change in cash | 13.80M | 1,360.11% |
Free cash flow | -10.04M | -89.66% |
About
Founded
2004
Headquarters
Website
Employees
31
